Another study observed that somatic mutations of EGFR were discordant between primary tumors and corresponding pleural metastases in a significant portion of lung adenocarcinomas, although the mutation frequency was higher in primary lesions compared with pleural metastases (35). Here, EGFR is linked to lung adenocarcinoma.